cimab
CIMAB S.A. is the exclusive representative for the commercialization of the products and services of the Center of Molecular Immunology (CIM), is a representative of “Laboratorios AICA” and the Cytostatics Plant CIDEM for the commercialization of some of products manufacturing in these institutions. CIMAB S.A. main mission is to export new biological medicines destined to the treatment of the cancer and other no transmissible chronic diseases once obtained the corresponding marketing approval.
innogene

Innogene Kalbiotech was incorporated in 2003 as a subsidiary of PT Kalbe Farma Tbk (Kalbe), which was established in 1966. Today, Kalbe is the largest publicly-listed pharmaceutical company in Southeast Asia and was named one of the “Most Admired Companies” 2014 by Fortune Indonesia.

innogene

Medison is Israel’s leading marketing group, representing innovative niche healthcare solutions companies such as Biogen, Amgen, Shire and Ipsen. Employing a comprehensive approach to sales and service, Medison supplies and maintains long-standing relations with HMOs (Health Maintenance Organizations), local medical centers and physicians. Backed by three generations of experience in the healthcare industry since 1937, Medison is uniquely qualified to provide the complete spectrum of integrated services for international companies looking to enter or expand their presence in the Israeli and Romanian healthcare markets.

innogene

Oncoscience was founded with the goal to fill gaps in the treatment of rare diseases, which cannot be covered by major pharmaindustrial companies. Oncoscience‘s mission and therefore the scientific benefit, lies in the research of rare diseases and the improvement of therapeutival possibilities. Because lack of overhead costs this is applicable to economic success. A group of experts in the field of oncology and its neccessities allows managing the business for patients and investors very cost effectively.

tearai
Te Arai Biofarma Limited is a 100% privately owned New Zealand company making innovative medicines available to New Zealanders. Named after a location in New Zealand of great significance to the company, Te Arai derives from the Maori language meaning “barrier or shield” and symbolises the benefit of medicines in general and the protection provided by vaccines in particular for the prevention of infectious diseases.
genilac

Gen Pharmaceuticals Inc. as a member of AG Corporation, joined Turkish pharmaceutical market in 1998 and aims to be the leading supplier of the orphan drugs for the treatments of rare diseases and innovative treatment alternatives for various disorders.